Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News

  News Archive

Human Protein Found to Block Zika Infection
Tuesday, June 07, 2016
Research shows that the human protein IFITM3 blocks Zika virus replication and prevents cell death.

How “Silent” Genetic Changes Drive Cancer
Friday, June 03, 2016
The researchers found that EXOSC2 expression is enhanced in metastatic tumors because their cells have increased levels of a tRNA called GluUUC.

Researchers Identify Protein That Could Prevent Tumor Growth
Friday, June 03, 2016
Researchers at UCLA have identified a protein that has the potential to prevent the growth of cervical cancer cells. The discovery could lead to the development of new treatments for the deadly disease.

New Muscular Dystrophy Drug Target Identified
Friday, June 03, 2016
Scientists at the University of Liverpool have discovered that muscle cells affected by muscular dystrophy contain high levels of an enzyme that impairs muscle repair. This finding provides a new target for potential drug treatments for the disease, which currently has no cure.

New "Druggable" Target for Sporadic Parkinson's Disease
Friday, June 03, 2016
Research at the Buck Institute shows the same mechanisms that lead to neuronal cell death in mice genetically fated to develop Parkinson’s disease (PD) are involved in the much more common sporadic form of the age-related, neurodegenerative disorder that robs people of the ability to move normally.

Olink Proteomics Opens US Facility
Wednesday, June 01, 2016
The new US laboratory facilities will help to meet the rapidly growing demands on the analysis service business, and provide a convenient, efficient touch-point for customers based in the United States.

Guarding the Gatekeepers
Wednesday, June 01, 2016
Latest research from the National Centre for Biological Sciences (NCBS), Bangalore, gives us new insights into how Orai proteins are regulated.

Applying Deep Learning to Drug Discovery
Wednesday, June 01, 2016
Researchers train deep neural networks to predict the therapeutic use of large number of multiple drugs using gene expression data obtained from high-throughput experiments on human cell lines.

Heart Attack Recovery Limited by Short Telomeres
Wednesday, June 01, 2016
Half of patients with CVD show no above-normal risk of developing the disease on the basis of classical risk factors, such as high cholesterol, smoking, lack of exercise, and high blood pressure.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 3384
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!